Gabriel Yariv
Vorsitzender bei CNBX PHARMACEUTICALS INC.
Profil
Gabriel Yariv was the founder of Instituto Simutec, founded in 2010, where he held the title of Chief Executive Officer from 2010 to 2017.
He was also the founder of The Yariv Foundation For Leadership Ltd., founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2009.
Mr. Yariv's current job(s) include being the Chairman & Chief Operating Officer at CNBX Pharmaceuticals, Inc. since 2019, a Director at TaGeza Biopharmaceuticals Ltd., and a Member at Friends of The Israel Museum Society.
Mr. Yariv's education history includes undergraduate studies at Boston University.
Aktive Positionen von Gabriel Yariv
Unternehmen | Position | Beginn |
---|---|---|
CNBX PHARMACEUTICALS INC. | Vorsitzender | 05.09.2021 |
Friends of The Israel Museum Society | Corporate Officer/Principal | - |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gabriel Yariv
Unternehmen | Position | Ende |
---|---|---|
Instituto Simutec | Gründer | 01.01.2017 |
The Yariv Foundation For Leadership Ltd. | Vorstandsvorsitzender | 01.01.2009 |
Ausbildung von Gabriel Yariv
Boston University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CNBX PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Instituto Simutec | |
Friends of The Israel Museum Society | |
The Yariv Foundation For Leadership Ltd. | |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Health Technology |